BCL-XL directly modulates RAS signalling to favour cancer cell stemness
Sophie de Carné Trécesson(The Francis Crick Institute), Philippe Juin(Centre National de la Recherche Scientifique)
Cited by 46
Related Papers
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
|Research Square|2024|0
EGFR/TBK1-dependent mitochondrial quality control contributes to acquired resistance to temozolomide
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0